Milestone Scientific shares rise 12.05% premarket after expanding pain management solutions with advanced technology integration.

Milestone Scientific surged 12.05% in premarket trading following a press release highlighting the company’s expansion of pain management solutions through the integration of advanced technology with traditional practices. The announcement emphasized efforts to reduce patient discomfort and anxiety, positioning the firm as an innovator in its sector. This strategic focus on technological advancement aligns with growing demand for non-invasive medical solutions, likely driving investor optimism and premarket buying activity.